FWBI Annual EBITDA
-$15.74 M
-$1.16 M-7.94%
31 December 2023
Summary:
As of January 28, 2025, FWBI annual earnings before interest, taxes, depreciation & amortization is -$15.74 million, with the most recent change of -$1.16 million (-7.94%) on December 31, 2023. During the last 3 years, it has risen by +$10.52 million (+40.06%).FWBI EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
FWBI Quarterly EBITDA
-$9.21 M
-$5.13 M-125.46%
31 March 2024
Summary:
As of January 28, 2025, FWBI quarterly earnings before interest, taxes, depreciation & amortization is -$9.21 million, with the most recent change of -$5.13 million (-125.46%) on March 31, 2024. Over the past year, it has dropped by -$5.13 million (-125.46%).FWBI Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
FWBI TTM EBITDA
-$20.90 M
-$5.16 M-32.77%
31 March 2024
Summary:
As of January 28, 2025, FWBI TTM earnings before interest, taxes, depreciation & amortization is -$20.90 million, with the most recent change of -$5.16 million (-32.77%) on March 31, 2024. Over the past year, it has dropped by -$5.16 million (-32.77%).FWBI TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
FWBI EBITDA Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -7.9% | -125.5% | -32.8% |
| 3 y3 years | +40.1% | -125.5% | -32.8% |
| 5 y5 years | -24.6% | -125.5% | -32.8% |
FWBI EBITDA High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | ||||||
| 5 y | 5-year | ||||||
| alltime | all time | +336.2% | -309.4% | +2329.7% |
First Wave BioPharma EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2024 | - | -$9.21 M(+125.5%) | -$20.90 M(+32.8%) |
| Dec 2023 | -$15.74 M(+7.9%) | -$4.09 M(+19.3%) | -$15.74 M(+0.7%) |
| Sept 2023 | - | -$3.43 M(-18.0%) | -$15.63 M(+100.3%) |
| June 2023 | - | -$4.18 M(+3.0%) | -$7.80 M(-13.5%) |
| Mar 2023 | - | -$4.05 M(+2.1%) | -$9.02 M(-38.1%) |
| Dec 2022 | -$14.58 M(-74.8%) | -$3.97 M(-190.3%) | -$14.58 M(-32.6%) |
| Sept 2022 | - | $4.40 M(-181.5%) | -$21.64 M(-61.6%) |
| June 2022 | - | -$5.40 M(-43.9%) | -$56.31 M(-6.2%) |
| Mar 2022 | - | -$9.61 M(-12.9%) | -$60.05 M(+3.6%) |
| Dec 2021 | -$57.98 M(+120.8%) | -$11.03 M(-63.5%) | -$57.98 M(-9.7%) |
| Sept 2021 | - | -$30.26 M(+231.0%) | -$64.21 M(+69.3%) |
| June 2021 | - | -$9.14 M(+21.1%) | -$37.92 M(+22.2%) |
| Mar 2021 | - | -$7.55 M(-56.3%) | -$31.03 M(+18.1%) |
| Dec 2020 | -$26.27 M(+91.4%) | -$17.26 M(+334.6%) | -$26.27 M(+162.9%) |
| Sept 2020 | - | -$3.97 M(+76.3%) | -$9.99 M(+0.4%) |
| June 2020 | - | -$2.25 M(-19.2%) | -$9.96 M(-20.3%) |
| Mar 2020 | - | -$2.79 M(+183.8%) | -$12.49 M(-9.0%) |
| Dec 2019 | -$13.72 M | -$982.10 K(-75.0%) | -$13.72 M(-17.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2019 | - | -$3.93 M(-17.8%) | -$16.57 M(+10.4%) |
| June 2019 | - | -$4.78 M(+18.8%) | -$15.00 M(+13.0%) |
| Mar 2019 | - | -$4.03 M(+5.2%) | -$13.28 M(+5.1%) |
| Dec 2018 | -$12.63 M(+33.4%) | -$3.82 M(+61.4%) | -$12.63 M(+15.8%) |
| Sept 2018 | - | -$2.37 M(-22.6%) | -$10.91 M(-1.6%) |
| June 2018 | - | -$3.06 M(-9.4%) | -$11.09 M(+8.6%) |
| Mar 2018 | - | -$3.38 M(+60.5%) | -$10.21 M(+7.9%) |
| Dec 2017 | -$9.47 M(+19.5%) | -$2.10 M(-17.4%) | -$9.47 M(+8.8%) |
| Sept 2017 | - | -$2.55 M(+16.8%) | -$8.70 M(+3.1%) |
| June 2017 | - | -$2.18 M(-17.1%) | -$8.44 M(-10.7%) |
| Mar 2017 | - | -$2.63 M(+96.2%) | -$9.46 M(+19.4%) |
| Dec 2016 | -$7.92 M(+119.4%) | -$1.34 M(-41.4%) | -$7.92 M(+23.4%) |
| Sept 2016 | - | -$2.29 M(-28.4%) | -$6.42 M(+21.1%) |
| June 2016 | - | -$3.20 M(+191.9%) | -$5.30 M(+37.9%) |
| Mar 2016 | - | -$1.09 M(-776.2%) | -$3.84 M(+6.5%) |
| Dec 2015 | -$3.61 M | $161.90 K(-113.8%) | -$3.61 M(-4.3%) |
| Sept 2015 | - | -$1.17 M(-32.7%) | -$3.77 M(+45.0%) |
| June 2015 | - | -$1.74 M(+102.2%) | -$2.60 M(+202.2%) |
| Mar 2015 | - | -$860.30 K | -$860.30 K |
FAQ
- What is First Wave BioPharma annual earnings before interest, taxes, depreciation & amortization?
- What is the all time high annual EBITDA for First Wave BioPharma?
- What is First Wave BioPharma annual EBITDA year-on-year change?
- What is First Wave BioPharma quarterly earnings before interest, taxes, depreciation & amortization?
- What is the all time high quarterly EBITDA for First Wave BioPharma?
- What is First Wave BioPharma quarterly EBITDA year-on-year change?
- What is First Wave BioPharma TTM earnings before interest, taxes, depreciation & amortization?
- What is the all time high TTM EBITDA for First Wave BioPharma?
- What is First Wave BioPharma TTM EBITDA year-on-year change?
What is First Wave BioPharma annual earnings before interest, taxes, depreciation & amortization?
The current annual EBITDA of FWBI is -$15.74 M
What is the all time high annual EBITDA for First Wave BioPharma?
First Wave BioPharma all-time high annual earnings before interest, taxes, depreciation & amortization is -$3.61 M
What is First Wave BioPharma annual EBITDA year-on-year change?
Over the past year, FWBI annual earnings before interest, taxes, depreciation & amortization has changed by -$1.16 M (-7.94%)
What is First Wave BioPharma quarterly earnings before interest, taxes, depreciation & amortization?
The current quarterly EBITDA of FWBI is -$9.21 M
What is the all time high quarterly EBITDA for First Wave BioPharma?
First Wave BioPharma all-time high quarterly earnings before interest, taxes, depreciation & amortization is $4.40 M
What is First Wave BioPharma quarterly EBITDA year-on-year change?
Over the past year, FWBI quarterly earnings before interest, taxes, depreciation & amortization has changed by -$5.13 M (-125.46%)
What is First Wave BioPharma TTM earnings before interest, taxes, depreciation & amortization?
The current TTM EBITDA of FWBI is -$20.90 M
What is the all time high TTM EBITDA for First Wave BioPharma?
First Wave BioPharma all-time high TTM earnings before interest, taxes, depreciation & amortization is -$860.30 K
What is First Wave BioPharma TTM EBITDA year-on-year change?
Over the past year, FWBI TTM earnings before interest, taxes, depreciation & amortization has changed by -$5.16 M (-32.77%)